Literature DB >> 18812558

Volumetric evaluation of liver metastases after thermal ablation: long-term results following MR-guided laser-induced thermotherapy.

Thomas J Vogl1, Nagy N N Naguib, Katrin Eichler, Thomas Lehnert, Hanns Ackermann, Martin G Mack.   

Abstract

PURPOSE: To volumetrically analyze liver metastases and posttherapeutic findings of the thermally ablated area after thermal ablation with magnetic resonance (MR)-guided laser-induced thermotherapy in a long-term evaluation using contrast-enhanced MR imaging.
MATERIALS AND METHODS: The study was approved by the institutional review board, and informed consent was obtained from all patients. In 40 patients (27 women, 13 men; age range, 33-94 years; mean age, 62.5 years) in whom colorectal cancer (n = 20) and breast cancer (n = 20) had metastasized to the liver, initial tumor volume and thermal-induced necrosis after MR-guided laser-induced thermotherapy were retrospectively analyzed. All patients presented with oligonodular liver metastases and underwent follow-up with contrast-enhanced MR imaging for at least 3 years. No concomitant oncologic therapies were performed.
RESULTS: Volumetric MR imaging evaluation depicted 40 metastases with an initial tumor volume less than 5 mL (x = 1.75), nine metastases with initial volume of 5-20 mL (x = 12.35), and eight metastases with initial volume more than 20 mL (x = 50.57). The mean volume of the thermally damaged area was 498% of the initial volume for colorectal cancer metastases and 604% of the initial volume for breast cancer metastases. The ischemic and necrotic volume for colorectal cancer metastases had decreased by a mean of 48.6% after 3 months, by 63% after 6 months, by 70.2% after 12 months, and by 92.2% after 36 months. For breast cancer metastases at 36 months, the necrotic volume had decreased by 80.61%; the reduction in the volume of the thermally damaged region was statistically significantly lower than that of colorectal cancer metastases.
CONCLUSION: MR-guided laser-induced thermotherapy induced a high volume of thermal ablation; the greatest reduction in the necrotic volume occurred in the first year, and lower values were seen in the next period. The reduction was statistically significantly higher in colorectal cancer metastases. RSNA, 2008

Entities:  

Mesh:

Year:  2008        PMID: 18812558     DOI: 10.1148/radiol.2491072079

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  12 in total

1.  The influence of Nd:YAG laser irradiation on Fluoroptic® temperature measurement: an experimental evaluation.

Authors:  Frank Hübner; Babak Bazrafshan; Jörg Roland; Antje Kickhefel; Thomas Josef Vogl
Journal:  Lasers Med Sci       Date:  2012-04-04       Impact factor: 3.161

2.  Velocity navigator for motion compensated thermometry.

Authors:  Florian Maier; Axel J Krafft; Joshua P Yung; R Jason Stafford; Andrew Elliott; Rüdiger Dillmann; Wolfhard Semmler; Michael Bock
Journal:  MAGMA       Date:  2011-03-04       Impact factor: 2.310

3.  Preclinical assessment of a 980-nm diode laser ablation system in a large animal tumor model.

Authors:  Kamran Ahrar; Ashok Gowda; Sanaz Javadi; Agatha Borne; Matthew Fox; Roger McNichols; Judy U Ahrar; Clifton Stephens; R Jason Stafford
Journal:  J Vasc Interv Radiol       Date:  2010-04       Impact factor: 3.464

Review 4.  The role of percutaneous image-guided ablation for lung tumors.

Authors:  Elena N Petre; Stephen B Solomon; Constantinos T Sofocleous
Journal:  Radiol Med       Date:  2014-07-01       Impact factor: 3.469

Review 5.  Recurrent breast cancer: treatment strategies for maintaining and prolonging good quality of life.

Authors:  Bernd Gerber; Mathias Freund; Toralf Reimer
Journal:  Dtsch Arztebl Int       Date:  2010-02-12       Impact factor: 5.594

Review 6.  Thermal tumor ablation in clinical use.

Authors:  C Brace
Journal:  IEEE Pulse       Date:  2011 Sep-Oct       Impact factor: 0.924

7.  Periodic contrast-enhanced computed tomography for thermal ablation monitoring: a feasibility study.

Authors:  Christopher L Brace; Charles A Mistretta; J Louis Hinshaw; Fred T Lee
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2009

8.  Application of a biodegradable macromolecular contrast agent in dynamic contrast-enhanced MRI for assessing the efficacy of indocyanine green-enhanced photothermal cancer therapy.

Authors:  Yi Feng; Lyska Emerson; Eun-Kee Jeong; Dennis L Parker; Zheng-Rong Lu
Journal:  J Magn Reson Imaging       Date:  2009-08       Impact factor: 4.813

9.  Ultrasound-guided laser-induced thermal therapy for small palpable invasive breast carcinomas: a feasibility study.

Authors:  S van Esser; G Stapper; P J van Diest; M A A J van den Bosch; J H G M Klaessens; W P Th M Mali; I H M Borel Rinkes; R van Hillegersberg
Journal:  Ann Surg Oncol       Date:  2009-06-09       Impact factor: 5.344

10.  MRI-guided laser ablation of neuroendocrine tumor hepatic metastases.

Authors:  Jukka Perälä; Rauli Klemola; Raija Kallio; Chengli Li; Ilkka Vihriälä; Pasi I Salmela; Osmo Tervonen; Roberto Blanco Sequeiros
Journal:  Acta Radiol Short Rep       Date:  2014-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.